Učitavanje...

JAK2 V617F in Myeloid Disorders: Molecular Diagnostic Techniques and Their Clinical Utility : A Paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology

In early 2005, several groups of investigators studying myeloid malignancies described a novel somatic point mutation (V617F) in the conserved autoinhibitory pseudokinase domain of the Janus kinase 2 (JAK2) protein, which plays an important role in normal hematopoietic growth factor signaling. The V...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autor: Steensma, David P.
Format: Artigo
Jezik:Inglês
Izdano: American Society for Investigative Pathology 2006
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1867618/
https://ncbi.nlm.nih.gov/pubmed/16931578
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2353/jmoldx.2006.060007
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!